Bill > S642

This bill, the Finn Sawyer Access to Cancer Testing Act, aims to facilitate the development of treatments for cancers by expanding Medicare and Medicaid coverage for certain cancer diagnostic and laboratory tests, such as microarray analysis, DNA sequencing, and RNA sequencing. The bill requires Medicare and Medicaid to cover these tests, with certain frequency limits, and exempts them from deductibles. Additionally, the bill directs the Secretary of Health and Human Services and the Director of the National Human Genome Research Institute to implement an education and awareness program for physicians and the public on the use of genomic testing and the role of genetic counselors, particularly in the context of cancer diagnosis and treatment.